Semi-Annual Consolidated Statement Of Income

COSMOS Pharmaceutical Corporation - Filing #7578936

Concept 2022-06-01 to
2022-11-30
2021-06-01 to
2021-11-30
Semi-annual consolidated statement of income
Statement of income
Net sales
404,016,000,000 JPY
371,138,000,000 JPY
Cost of sales
320,803,000,000 JPY
296,944,000,000 JPY
Gross profit (loss)
83,213,000,000 JPY
74,193,000,000 JPY
Ordinary profit (loss)
16,900,000,000 JPY
16,494,000,000 JPY
Extraordinary income
26,000,000 JPY
268,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
67,827,000,000 JPY
59,214,000,000 JPY
Extraordinary losses
161,000,000 JPY
127,000,000 JPY
Operating profit (loss)
15,385,000,000 JPY
14,979,000,000 JPY
Profit (loss) before income taxes
16,764,000,000 JPY
16,636,000,000 JPY
Non-operating income
Interest income
23,000,000 JPY
25,000,000 JPY
Non-operating income
1,817,000,000 JPY
1,847,000,000 JPY
Non-operating expenses
Interest expenses
23,000,000 JPY
27,000,000 JPY
Non-operating expenses
302,000,000 JPY
332,000,000 JPY
Income taxes
5,465,000,000 JPY
5,390,000,000 JPY
Profit (loss)
11,299,000,000 JPY
11,245,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
JPY
265,000,000 JPY
Extraordinary losses
Loss on disaster
44,000,000 JPY
27,000,000 JPY
Profit (loss) attributable to owners of parent
11,299,000,000 JPY
11,245,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
0 JPY
0 JPY
Remeasurements of defined benefit plans, net of tax
4,000,000 JPY
7,000,000 JPY
Other comprehensive income
5,000,000 JPY
7,000,000 JPY
Comprehensive income
11,304,000,000 JPY
11,253,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
11,304,000,000 JPY
11,253,000,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.